Caretaker Medical and Red One Medical have partnered to enable safer healthcare for U.S. veterans at VA hospitals. Caretaker’s VitalStream® will offer VA medical centers the ability to continuously and non-invasively monitor blood pressure, cardiac output, stroke volume, fluid responsiveness and other advanced hemodynamic parameters throughout all hospital departments. This level of monitoring has been …

ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute inflammatory diseases, announced that the first patient has been dosed in its Phase 2 study of RLS-0071, the Company’s lead therapeutic candidate, for the treatment of hospitalized patients with …

Hampton Roads stands at the forefront of innovation by announcing a $2.4 million federal grant to enhance care for Alzheimer’s and dementia patients. This funding, spearheaded by Congresswoman Jen Kiggans, not only highlights the region’s commitment to healthcare but also emphasizes the role of local startups like Nasoni, which are driving the future of patient …

Children’s National Hospital, widely recognized for its expertise and innovation in pediatric care, has been chosen by the Biomedical Advanced Research and Development Authority (BARDA) to lead the Special Populations Hub in the next generation of the BARDA Accelerator Network. BARDA, is part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. …

Three Southwest Virginia biomedical companies that need sterile space for manufacturing will be part of a modular cleanroom pilot program. A $100,000 grant from economic development initiative GO Virginia and $221,500 in non-state money will fund the project, according to a GO Virginia news release. Cancer-fighting businesses Tiny Cargo Co. and Acomhal Research, both in …

Today, the Biotechnology Innovation Organization (BIO) awarded Virginia Governor Glenn Youngkin with its 2024 Governor of the Year Award. BIO’s annual award honors governors for their leadership and commitment to strengthening biotechnology in their state. For over a decade, the award has recognized governors from across the country and both sides of the aisle. “Investing …

Activation Capital proudly announces the launch of Start-the-Journey, a new BioHealth Pre-Accelerator designed to equip early-stage biotech and life science entrepreneurs with the knowledge and tools to build successful startups. Powered by Fat Robin Consulting, this innovative program supports founders in the initial phases of their entrepreneurial journey, preparing them for more advanced initiatives like …

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the United States Food and Drug Administration (U.S. FDA) has approved Ocrevus Zunovo™ (ocrelizumab & hyaluronidase-ocsq) for the treatment of relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS). Ocrevus Zunovo is the first and only twice-a-year, healthcare professional …

VaLogic Bio, a platform company of 424 Capital and a leading provider of compliance and SaaS services to the life sciences industry, proudly announces the acquisition of Facility Logix (FLGX), a renowned firm specializing in planning, developing, and project management for life sciences facilities. This acquisition aligns with VaLogic Bio’s strategic vision to enhance its …

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq HybrezaTM (atezolizumab and hyaluronidase-tqjs), the first and only PD-(L)1 inhibitor for subcutaneous (SC), under the skin injection for patients in the United States. Tecentriq Hybreza can be injected subcutaneously over approximately …

Governor Glenn Youngkin today announced that American Type Culture Collection will invest $54.7 million to expand its bioresource center campus in Prince William County with a new biomanufacturing facility focused on global health. ATCC is a private, nonprofit global biological resource center and standards organization that provides scientists with the biomaterials and resources they need …

A startup company with roots at Virginia Commonwealth University has received a prestigious state grant that will accelerate its work in advancing DNA analysis. Now housed in incubator office space in the Richmond neighborhood of Scott’s Addition, Evizia is building on more than a decade of published research and grants tied to its husband-and-wife co-founders …

NImmune Biopharma (“NImmune”), a late-clinical-stage precision immunology biopharmaceutical company that develops novel best-in-class biomarker-driven immunoregulatory therapeutics, today announced a research collaboration with BioTherapeutics, Inc. (“BioTherapeutics”), a clinical-stage biotech company that combines advanced computational modeling with translational and clinical experimentation to accelerate the development of novel products. The collaboration strengthens NImmune’s precision immunology capabilities by providing …

Governor Glenn Youngkin announced that Canon Virginia, Inc., a leading global manufacturer of consumer and office products, will expand its manufacturing facility in the City of Newport News. The expansion will support Canon’s new initiative to scale a unique method of isolating natural silk protein to create a solution with applications for multiple industries. Canon …

AgroSpheres, a biotechnology leader in sustainable crop protection and crop health, today announced that its first biofungicide, powered by the novel AgriCell technology, has received approval from the Environmental Protection Agency (EPA) following a comprehensive review. This approval allows the company to commence commercial production, bringing its innovative bioplatform technology directly to growers. The proprietary …

LumaCyte, a leader in advanced cellular analysis and precision bioanalytics, proudly announces the launch of its groundbreaking cell therapy application for predictive CAR T donor analytics. Leveraging its novel Laser Force Cytology™ (LFC™) technology and Radiance® instrument, LumaCyte uncovers deep data insights into highly variable and complex patient and donor cellular starting material, enabling cell …

ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute inflammatory diseases, announced that Peter Ho, Ph.D., has joined the Company as Head of Business Development and Corporate Strategy. “I am thrilled to have Peter join our executive team …

Activation Capital, an innovation ecosystem development organization, has announced the selection of 10 fast-growing startups from across the country for the inaugural Frontier BioHealth program, which commenced with an in-person gathering on August 8-9, 2024. Each company will benefit from highly specialized training, targeted mentorship, and extensive relationship-building opportunities to accelerate its growth in the life …

ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute inflammatory diseases, today announced two distinguished biopharmaceutical veterans to lead the Company: David Marek appointed as Chief Executive Officer and Paolo Martini, Ph.D., appointed as Chief Research and Development …

A senior business leader in the development and translation of biomedical science innovation through the commercialization pipeline has joined Virginia Tech to facilitate the growth of the academic health sciences research enterprise through building strategic industry partnerships and facilitating commercialization of discoveries. Sally Allain, formerly the head of Johnson & Johnson Innovation JLABS @ Washington, …

The Alliance for Pediatric Device Innovation (APDI), a nonprofit consortium led by Children’s National Hospital and funded by the Food and Drug Administration (FDA), announces today it is partnering with Additional Ventures, a nonprofit foundation focused on accelerating research progress and improving clinical care for individuals born with single ventricle heart defects, to solicit proposals …

ReAlta Life Sciences, Inc., a clinical-stage biotech company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute inflammatory diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation and Fast Track Designation to RLS-0071, the Company’s lead therapeutic candidate, for the treatment of hospitalized patients …

Researchers at Virginia Commonwealth University could soon launch a clinical trial to test an intravenous solution that its inventor, a School of Medicine physiologist and surgery professor, says might treat massive blood loss in trauma patients. Perfusion Medical Inc., a VCU startup working to commercialize the drug called PM-208, has received $1.8 million from the …

Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving metabolic health, today announced its Phase 2a HuMAIN clinical trial of HU6 in patients with obesity-related heart failure with preserved ejection fraction (HFpEF) met its primary endpoint of weight reduction. HU6, an oral, once-daily potentially first-in-class investigational treatment, is a Controlled Metabolic Accelerator (CMA), which …